Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod [Internet]. 2011;26:1768–74. [cited 2022 Mar 16] Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/21558332/

Article  PubMed  Google Scholar 

Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril [Internet]. 2018;110:661–670.e1. [cited 2021 Mar 4]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/30196963/

Article  PubMed  Google Scholar 

Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis. Hum Reprod [Internet]. 2019;34:491–505. [cited 2022 Mar 17]; Available from: https://academic.oup.com/humrep/article/34/3/491/5303709

Article  CAS  PubMed  Google Scholar 

Roque M, Haahr T, Geber S, Esteves SC, Humaidan P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update [Internet]. 2019;25:2–14. [cited 2022 Jun 25] Available from: https://academic.oup.com/humupd/article/25/1/2/5155324

Article  PubMed  Google Scholar 

Boynukalin FK, Turgut NE, Gultomruk M, Ecemis S, Yarkiner Z, Findikli N, et al. Impact of elective frozen vs. fresh embryo transfer strategies on cumulative live birth: Do deleterious effects still exist in normal & hyper responders? PLoS One. 2020;15 [cited 2022 Mar 17]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/32589634/

Ioannidou PG, Bosdou JK, Lainas GT, Lainas TG, Grimbizis GF, Kolibianakis EM. How frequent is severe ovarian hyperstimulation syndrome after GnRH agonist triggering in high-risk women? A systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2021;42:635–50. [cited 2022 Jun 21]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/33483281/

Article  CAS  PubMed  Google Scholar 

Orvieto R. Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod [Internet]. 2005;20:320–2. [cited 2023 Mar 16]; Available from: https://pubmed.ncbi.nlm.nih.gov/15567876/

Article  PubMed  Google Scholar 

Committee of the American Society for Reproductive Medicine P, Pfeifer S, Butts MSCES, Dumesic D, Fossum G, Gracia MSCEC, et al. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril [Internet]. 2016;106:1634–47. https://doi.org/10.1016/j.fertnstert.2016.08.048.

Article  Google Scholar 

Feferkorn I, Ata B, Esteves SC, La Marca A, Paulson R, Blockeel C, et al. The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization. J Assist Reprod Genet. 2023; [cited 2023 Mar 21]; Available from: https://pubmed.ncbi.nlm.nih.gov/36933094/

Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967–73.

Article  PubMed  Google Scholar 

Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril. 2018;110:661–670.e1.

Article  PubMed  Google Scholar 

Magnusson Å, Källen K, Thurin-Kjellberg A, Bergh C. The number of oocytes retrieved during IVF: a balance between efficacy and safety. Hum Reprod [Internet]. 2018;33:58–64. [cited 2022 Apr 27]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/29136154/

Article  PubMed  Google Scholar 

Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil Steril [Internet]. 2011;96:516–8. [cited 2022 Jun 25]; Available from: https://pubmed.ncbi.nlm.nih.gov/21737071/

Article  PubMed  Google Scholar 

Chen Z-J, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. New Engl J Med [Internet]. 2016;375:523–33. [cited 2022 Apr 20]; Available from: https://www.nejm.org/doi/10.1056/NEJMoa1513873

Article  PubMed  Google Scholar 

Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod [Internet]. 2016;31:1253–64. [cited 2022 Jul 10]; Available from: https://academic.oup.com/humrep/article/31/6/1253/1749630

Article  CAS  PubMed  Google Scholar 

Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI†. Hum Reprod Open [Internet]. 2020;2020:1–13. [cited 2022 Mar 23]; Available from: https://academic.oup.com/hropen/article/2020/2/hoaa009/5827574

Google Scholar 

Oudshoorn SC, van Tilborg TC, Eijkemans MJC, Oosterhuis GJE, Friederich J, van Hooff MHA, et al. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: the predicted hyper responder. Hum Reprod [Internet]. 2017;32:2506–14. [cited 2022 Apr 30]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/29121269/

Article  CAS  PubMed  Google Scholar 

Lensen SF, Wilkinson J, Leijdekkers JA, la Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev. 2018;2 [cited 2022 Jun 24]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/29388198/

Friis Petersen J, Løkkegaard E, Andersen LF, Torp K, Egeberg A, Hedegaard L, et al. A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF. Hum Reprod Open [Internet]. 2019;2019 [cited 2022 Jun 24]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/30895268/

Mannaerts BMJL, Rombout F, Out HJ, Bennink HC. Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod Update [Internet]. 1996;2:153–61. [cited 2022 Jun 24]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/9079410/

Article  CAS  PubMed  Google Scholar 

Rose TH, Röshammar D, Erichsen L, Grundemar L, Ottesen JT. Population pharmacokinetic modelling of FE 999049, a recombinant human follicle-stimulating hormone, in healthy women after single ascending doses. Drugs R D [Internet]. 2016;16:173–80. [cited 2022 Jun 24]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/27003895/

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rose TH, Röshammar D, Erichsen L, Grundemar L, Ottesen JT. Characterisation of population pharmacokinetics and endogenous follicle-stimulating hormone (FSH) levels after multiple dosing of a recombinant human FSH (FE 999049) in healthy women. Drugs RD [Internet]. 2016;16:165–72. [cited 2022 Jun 24]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/27139012/

Article  CAS  Google Scholar 

Ledger WL, Fauser BCJM, Devroey P, Zandvliet AS, BMJL M. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online [Internet]. 2011;23:150–9. [cited 2022 Jun 24]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/21665541/

Article  CAS  PubMed  Google Scholar 

Leijdekkers JA, van Tilborg TC, Torrance HL, Oudshoorn SC, Brinkhuis EA, Koks CAM, et al. Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial. Acta Obstet Gynecol Scand [Internet]. 2019;98:1332–40. [cited 2022 Jun 24]; Available from: https://onlinelibrary-wiley-com.proxy3.library.mcgill.ca/doi/full/10.1111/aogs.13664

Article  CAS  PubMed  Google Scholar 

Lainas GT, Lainas TG, Sfontouris IA, Venetis CA, Bosdou JK, Chatzimeletiou A, et al. Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study. Reprod Biomed Online [Internet]. 2020;40:168–75. [cited 2022 Jun 21]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/31839394/

Article  CAS  PubMed  Google Scholar 

Aboulghar MA, Mansour RT, Serour GI, Rhodes CA, Amin YM. Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation. J Assist Reprod Genet [Internet]. 2000;17:298. [cited 2022 Aug 26]; Available from: /pmc/articles/PMC3455203/

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fatemi H, Bilger W, Denis D, Griesinger G, la Marca A, Longobardi S, et al. Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017). Reprod Biol Endocrinol [Internet]. 2021;19 [cited 2022 Aug 26] Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/33975610/

Mahony MC, Hayward B, Mottla GL, Richter KS, Beall S, Ball GD, et al. Recombinant human follicle-stimulating hormone alfa dose adjustment in US clinical practice: an observational, retrospective analysis of a real-world electronic medical records database. Front Endocrinol (Lausanne) [Internet]. 2021;12 [cited 2022 Aug 26]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/34956077/

D’Angelo A, Brown J, Amso NN. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev [Internet]. 2011; [cited 2022 Aug 26]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/21678336/

D’Angelo A, Amso NN, Hassan R. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev [Internet]. 2017;5 [cited 2022 Aug 26]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/28535578/

Palomba S, Falbo A, Russo T, Orio F, Tolino A, Zullo F. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Hum Reprod. 2010;25:1005–13. [cited 2022 Aug 28]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/20106839/

Article  CAS  PubMed  Google Scholar 

Tso LO, Costello MF, Albuquerque LET, Andriolo RB, Macedo CR. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;12 [cited 2022 Jun 23] Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/33347618/

Wu Y, Tu M, Huang Y, Liu Y, Zhang D. Association of metformin with pregnancy outcomes in women with polycystic ovarian syndrome undergoing in vitro fertilization: a systematic review and meta-analysis. JAMA Netw Open [Internet]. 2020;3:e2011995. [cited 2022 Jun 23]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/32744629/

Article  PubMed  PubMed Central  Google Scholar 

Siristatidis CS, Basios G, Pergialiotis V, Vogiatzi P. Aspirin for in vitro fertilisation. Cochrane Database Syst Rev. 2016;11 [cited 2022 Aug 26]; Available from: https://pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca/27807847/

Orvieto R. Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos. Human Reproduction [Internet]. 2003;18:665–7. [cited 2022 Apr 4]; Available from: https://academic.oup.com/humrep/article/18/4/665/596582

Article  CAS  PubMed  Google Scholar 

Orvieto R. Controlled ovarian hyperstimulation - an inflammatory state. J Soc Gynecol Investig. 2004;11:424–6.

Article  CAS  PubMed  Google Scholar 

Orvieto R, Ben-Rafael Z. Ovarian hyperstimulation syndrome: a new insight into an old enigma. J Soc Gynecol Investig [Internet]. 1998;5:110–3. [cited 2023 Mar 16]; Available from: https://pubmed.ncbi.nlm.nih.gov/9614638/

Article  CAS  PubMed  Google Scholar 

Ata B, Tulandi T. Pathophysiology of ovarian hyperstimulation syndrome and strategies for its prevention and treatment. Expert Rev Obstet Gynecol. 2014;4:299–311. https://doi.org/10.1586/eog.09.10.

Article